oncology
The data-driven blood glucose monitor system-maker will use the money to push into new areas of disease management, such as cardiology, oncology and women's health.
The service enables patients from the region to make informed decisions about cancer care, with the aim of expanding their treatment options and improving clinical outcomes.
As part of the acquisition Kaiku Health's symptom-tracking tool will be integrated into Elekta's oncology informatics platform.
The new funds will be put towards growing its diagnostic and testing products.
The latest round was led by Atlanta Technology Angels and the Robbins Fund.
Health Venture Partners led the round with participation from Breyer Capital, Kenan Turnacioglu and other funders.
The startup develops non-invasive blood tests that achieve early cancer detection and improve treatment selection.
The new office will support the firm’s plans for advanced injection, wearable devices and connected health technologies.
These include Wellthy Therapeutics, from India; OKKO Health, from the UK; and Carepay, from Kenya.
Oleena's algorithms serve patients personalized guidance on how best to mitigate symptoms, while also monitoring and generating insights for their care team.